The price is accelerating after sales forecasts for Q4 were raised.
Clear compression with a retest of the previous low, the price is now heading toward the blue resistance around $170, and in case of a breakout, could continue toward $208.
The medical sector has been largely overlooked in recent years in favor of AI stocks, but a renewed interest in 2026 is very likely.
Clear compression with a retest of the previous low, the price is now heading toward the blue resistance around $170, and in case of a breakout, could continue toward $208.
The medical sector has been largely overlooked in recent years in favor of AI stocks, but a renewed interest in 2026 is very likely.
ノート
Ready for a breakoutノート
breakout confirmed
免責事項
この情報および投稿は、TradingViewが提供または推奨する金融、投資、トレード、その他のアドバイスや推奨を意図するものではなく、それらを構成するものでもありません。詳細は利用規約をご覧ください。
免責事項
この情報および投稿は、TradingViewが提供または推奨する金融、投資、トレード、その他のアドバイスや推奨を意図するものではなく、それらを構成するものでもありません。詳細は利用規約をご覧ください。